• Email Preferences
    • Logout
    loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
    • Email Preferences
    • Logout
    loading
    Member
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 75
  3. 76
  4. 77
  5. 78
  6. 79
  7. …
  • Alberta extends quarantine period for contacts of COVID variant patients

    Canada // 03 February, 2021

    Isolation/quarantine of COVID variant cases increased

    COVID-19

  • Interim authorisation for Moderna Vaccine

    Singapore // 03 February, 2021

    Interim authorisation granted to Moderna

    COVID-19

  • Single dose of Oxford AstraZeneca vaccine provides 76% protection, may help prevent transmission

    03 February, 2021

    The Oxford AstraZeneca COVID-19 vaccine is shown to offer 76 % protection for up to 12 weeks after...

    COVID-19

  • Uganda purchases AstraZeneca COVID-19 vaccine

    Uganda // 03 February, 2021

    Media sources report that Uganda has purchased 18 million doses of Covishield, the AstraZeneca COVID-19 vaccine ...

    COVID-19

  • COVID Vaccination update, Sputnik V granted EUA

    Mexico // 03 February, 2021

    EUA for Sputnik V

    COVID-19

  • CDC updates mRNA vaccines recommendations, includes pain relievers, dermal fillers

    United States // 03 February, 2021

    Updated guidance on Pfizer-BioNTech and Moderna COVID-19 vaccines with respect to pain relievers and other common queries

    COVID-19

  • COVID-19 vaccines in retail pharmacies

    United States // 03 February, 2021

    Limited supply in pharmacies

    COVID-19

  • Vaccination campaign to begin in mid-February

    Japan // 03 February, 2021

    Vaccine campaigns are expected to begin with the Pfizer-BioNTech vaccine from mid-February...

    COVID-19

  • AstraZeneca vaccine restricted for under 65s

    France // 02 February, 2021

    Due to insufficient data...

    COVID-19

  • Sputnik V vaccine 91.6% effective

    Russia // 02 February, 2021

    And well tolerated in a large cohort...

    COVID-19

  • Barcitinib added in RECOVERY trial as a possible COVID-19 treatment

    02 February, 2021

    There has been some clinical trial evidence that baricitinib, an anti-inflammatory treatment for rheumatoid arthritis, may be beneficial against COVID-19...

    COVID-19

  • Comparing vaccines in the United Kingdom

    United Kingdom // 02 February, 2021

    A look at the vaccines approved and in review in the United Kingdom...

    COVID-19

  • US COVID-19 cases caused by variants

    United States // 02 February, 2021

    The CDC is tracking COVID-19 cases caused by variants in the US...

    COVID-19

  • Possible reasons for testing positive for coronavirus after vaccination

    02 February, 2021

    There are several reasons why people may still test positive for Coronavirus even after vaccination....

    COVID-19

  • Deaths after Pfizer COVID vaccines not linked to shots

    02 February, 2021

    No link between the Pfizer-BioNTech vaccine and fatalities were found...

    COVID-19

  • “Dodged a bullet”: Melbourne lockdown may have prevented more deadly variants

    Australia // 02 February, 2021

    Experts say the extended lockdown in Melbourne during 2020 has helped with...

    COVID-19

  • UK detects B.1.351 coronavirus variant in people with no travel links

    United Kingdom // 02 February, 2021

    ... and will begin door-to-door testing of people in affected areas...

    COVID-19

  • Portugal severely affected by B.1.1.7 variant

    Portugal // 02 February, 2021

    The B.1.1.7 variant is causing concern in Portugal, while other affected countries have decreasing trends...

    COVID-19

  • Mike Osterholm predicts that B.1.1.7 will be like a hurricane for the US

    United States // 02 February, 2021

    ...and recommends that the US increases the number of people who have received the first vaccine dose...

    COVID-19

  • Co-infections with two SARS-CoV-2 variants

    Brazil // 02 February, 2021

    Doctors have reported two COVID-19 patients simultaneously infected with two different virus strains...

    COVID-19

  1. …
  2. 75
  3. 76
  4. 77
  5. 78
  6. 79
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS